283 related articles for article (PubMed ID: 33583102)
1. Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies.
Silmore LH; Willmer AR; Capparelli EV; Rosania GR
Pharmacotherapy; 2021 Apr; 41(4):405-420. PubMed ID: 33583102
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.
Izgelov D; Davidson E; Barasch D; Regev A; Domb AJ; Hoffman A
Eur J Pharm Biopharm; 2020 Sep; 154():108-115. PubMed ID: 32634571
[TBL] [Abstract][Full Text] [Related]
3. Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol.
Kok LY; Bannigan P; Sanaee F; Evans JC; Dunne M; Regenold M; Ahmed L; Dubins D; Allen C
Eur J Pharm Sci; 2022 Jan; 168():106058. PubMed ID: 34763088
[TBL] [Abstract][Full Text] [Related]
4. Improved Bioavailability with Dry Powder Cannabidiol Inhalation: A Phase 1 Clinical Study.
Devinsky O; Kraft K; Rusch L; Fein M; Leone-Bay A
J Pharm Sci; 2021 Dec; 110(12):3946-3952. PubMed ID: 34400185
[TBL] [Abstract][Full Text] [Related]
5. Model-Based Analysis of Cannabidiol Dose-Exposure Relationship and Bioavailability.
Lim SY; Sharan S; Woo S
Pharmacotherapy; 2020 Apr; 40(4):291-300. PubMed ID: 32058609
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.
Atsmon J; Heffetz D; Deutsch L; Deutsch F; Sacks H
Clin Pharmacol Drug Dev; 2018 Sep; 7(7):751-758. PubMed ID: 29125702
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and oral bioavailability of cannabidiol in horses after intravenous and oral administration with oil and micellar formulations.
Sánchez de Medina A; Serrano-Rodríguez JM; Díez de Castro E; García-Valverde MT; Saitua A; Becero M; Muñoz A; Ferreiro-Vera C; Sánchez de Medina V
Equine Vet J; 2023 Nov; 55(6):1094-1103. PubMed ID: 36624043
[TBL] [Abstract][Full Text] [Related]
8. A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb
Knaub K; Sartorius T; Dharsono T; Wacker R; Wilhelm M; Schön C
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426272
[TBL] [Abstract][Full Text] [Related]
9. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
[TBL] [Abstract][Full Text] [Related]
10. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
[TBL] [Abstract][Full Text] [Related]
11. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
[TBL] [Abstract][Full Text] [Related]
12. A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study.
Vitetta L; Butcher B; Henson JD; Rutolo D; Hall S
Inflammopharmacology; 2021 Oct; 29(5):1361-1370. PubMed ID: 34357480
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.
Koch N; Jennotte O; Bourcy Q; Lechanteur A; Deville M; Charlier C; Chiap P; Cardot JM; Evrard B
Int J Pharm; 2024 May; 657():124173. PubMed ID: 38685441
[TBL] [Abstract][Full Text] [Related]
14. Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical Implications.
Perucca E; Bialer M
CNS Drugs; 2020 Aug; 34(8):795-800. PubMed ID: 32504461
[TBL] [Abstract][Full Text] [Related]
15. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
16. A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray.
Stott CG; White L; Wright S; Wilbraham D; Guy GW
Eur J Clin Pharmacol; 2013 Apr; 69(4):825-34. PubMed ID: 23052407
[TBL] [Abstract][Full Text] [Related]
17. Food effect on pharmacokinetics of cannabidiol oral capsules in adult patients with refractory epilepsy.
Birnbaum AK; Karanam A; Marino SE; Barkley CM; Remmel RP; Roslawski M; Gramling-Aden M; Leppik IE
Epilepsia; 2019 Aug; 60(8):1586-1592. PubMed ID: 31247132
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis.
Moazen-Zadeh E; Chisholm A; Bachi K; Hurd YL
Cannabis Cannabinoid Res; 2023 Aug; ():. PubMed ID: 37643301
[No Abstract] [Full Text] [Related]
19. Pharmacokinetics of Cannabidiol: A systematic review and meta-regression analysis.
Moazen-Zadeh E; Chisholm A; Bachi K; Hurd YL
medRxiv; 2023 Feb; ():. PubMed ID: 36778355
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Food on Cannabidiol Bioaccessibility.
Mozaffari K; Willette S; Lucker BF; Kovar SE; Holguin FO; Guzman I
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
